REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact
University of Navarra
UN is a Spanish leading private university with more than 13,849 students (27,4% internationals) in 7 campuses: Pamplona, San Sebastian, Madrid, Barcelona, New York, Munich, and Sâo Paulo. UN is among the top one hundred universities in the world in six areas, according to the QS World University Rankings by subjects in its 2021 edition. Moreover, it has been ranked in 7 of the 11 subject areas (Arts and Humanities; Business and Economics; Clinical and Health; Engineering; Law; Life Sciences and Social Sciences) in the 2021 Times Higher Education Subject Rankings. The University has been awarded with the HR Excellence in Research seal on 14 September 2020 which accredits the commitment to quality in the management of human resources in research.
The Brucellosis-UN team has a large track record in the study (bacteriological, serological, and molecular) of animal and human brucellosis that has produced, among others, two diagnostic tools (native hapten immunoprecipitation test and an improved multiplex-PCR for molecular typing [commercialized by INGENASA]) recommended in the OIE Manual of Diagnostic Tests and Vaccine for Terrestrial Animals (bovine brucellosis). The group has the expertise and infrastructure necessary for antigen production and control, evaluation of diagnostic tests and Brucella typing, and has organized international brucellosis courses sponsored by WHO, OIE - FAO, EU and United Nations agencies in Spain, Mozambique, Tanzania, Uganda and Kenya.
During the last 10 years, the group has participated in 11 competitive projects (5 International, 3 National and 3 regional projects), published 62 papers in Science Citation Index international journals and contributed with more than 70 presentations in research conferences (including 5 invitations). The research of the group has led to collaborations with companies (EUROFINS-INGENASA and AQUILON) as well as to the participation of the scientific group in two consortia (Cooper Zeltia Vaccines-Centro de Investigación en Tecnología Agroalimentaria de Zaragoza-Universidad de Navarra, and Virbac-Centre d'Immunologie de Marseille-Luminy-Universidad de Navarra) each one recently awarded a first phase prize in the GALVMed competition (Development of a new vaccine against animal brucellosis (https://www.galvmed.org/novel-initiative-newbrucellosis- vaccine/). The group holds two patents on the field of vaccine development.
Finally, Brucellosis-UN team is member of the Institute of Tropical Health University of Navarra (https://en.unav.edu/web/institute-of-tropical-health/research)
- Raquel Conde Álvarez (PI)
- Maite Iriarte Cilveti
- Amaia Zúñiga Ripa
- Miriam Salvador Bescós
- Maite Loperena Barber
- Aitor Elizalde Bielsa
- Nerea Lopez Fernández